Global Survey on Pancreatic Surgery During the COVID-19 Pandemic
Objective:
The aim of this study was to clarify the role of pancreatic surgery during the COVID-19 pandemic to optimize patients’ and clinicians’ safety and safeguard health care capacity.
Summary Background Data:
The COVID-19 pandemic heavily impacts health care systems worldwide. Cancer patients appear to have an increased risk for adverse events when infected by COVID-19, but the inability to receive oncological care seems may be an even larger threat, particularly in case of pancreatic cancer.
Methods:
An online survey was submitted to all members of seven international pancreatic associations and study groups, investigating the impact of the COVID-19 pandemic on pancreatic surgery using 21 statements (April, 2020). Consensus was defined as>80% agreement among respondents and moderate agreement as 60% to 80% agreement.
Results:
A total of 337 respondents from 267 centers and 37 countries spanning 5 continents completed the survey. Most respondents were surgeons (n = 302, 89.6%) and working in an academic center (n = 286, 84.9%). The majority of centers (n = 166, 62.2%) performed less pancreatic surgery because of the COVID-19 pandemic, reducing the weekly pancreatic resection rate from 3 [interquartile range (IQR) 2–5] to 1 (IQR 0–2) (P
Source: Annals of Surgery - Category: Surgery Tags: COVID PAPERS Source Type: research
More News: Academia | Cancer | Cancer & Oncology | COVID-19 | Health Management | Pancreas | Pancreatic Cancer | Pandemics | Study | Surgery